Variant report
Variant | esv1811887 |
---|---|
Chromosome Location | chr3:162765807-162773033 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs138024582 | chr3:162766096-162766097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs111799106 | chr3:162766147-162766148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs149078902 | chr3:162766375-162766376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs568026225 | chr3:162766406-162766407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs60074051 | chr3:162766537-162766538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs148262749 | chr3:162766583-162766584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs193263847 | chr3:162766815-162766816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs142896917 | chr3:162767079-162767080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs147244869 | chr3:162767086-162767087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs111440250 | chr3:162767102-162767103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs183651912 | chr3:162767264-162767265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs567571277 | chr3:162767345-162767346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs112417937 | chr3:162767498-162767499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs189045392 | chr3:162767555-162767556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542900095 | chr3:162767556-162767557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs150858672 | chr3:162767689-162767690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191585318 | chr3:162767701-162767702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112147043 | chr3:162767741-162767742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565416890 | chr3:162767797-162767798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs150026608 | chr3:162767824-162767825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs144341954 | chr3:162767867-162767868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs113156412 | chr3:162767888-162767889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs143947821 | chr3:162767982-162767983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549964498 | chr3:162768121-162768122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538595079 | chr3:162768127-162768128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs553798774 | chr3:162768246-162768247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs569047855 | chr3:162768357-162768358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs146662065 | chr3:162768358-162768359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs112393075 | chr3:162768458-162768459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs571194307 | chr3:162768495-162768496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs533586124 | chr3:162768496-162768497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs183723957 | chr3:162768655-162768656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs142523566 | chr3:162768794-162768795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs536355810 | chr3:162768827-162768828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555953490 | chr3:162769081-162769082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs576599529 | chr3:162769082-162769083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs545255775 | chr3:162769083-162769084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs200504044 | chr3:162769084-162769085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs146295624 | chr3:162769107-162769108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150949082 | chr3:162769138-162769139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs9823925 | chr3:162769145-162769146 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs188783500 | chr3:162769184-162769185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs533124260 | chr3:162769203-162769204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9824108 | chr3:162769266-162769267 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs530005630 | chr3:162769274-162769275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543916847 | chr3:162769287-162769288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs200907721 | chr3:162769303-162769304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs9841791 | chr3:162769378-162769379 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs531570458 | chr3:162769403-162769404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs140782821 | chr3:162769404-162769405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:162765000-162769000 | Weak transcription | Dnd41 | blood |
2 | chr3:162765600-162766000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr3:162769000-162770200 | Enhancers | Dnd41 | blood |
4 | chr3:162771600-162772000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |